PIB Tracker66.80 lakh psychotropic tablets seized on the Chandigarh-Baddi route
The tablets were legally manufactured medicines — Alprazolam, Tramadol, Nitrazepam and Clonazepam — with batch numbers and expiry dates erased, moving without invoices into the Punjab-Himachal corridor.
What happened
- The CBN MP Unit seized 66,79,980 psychotropic tablets on the Chandigarh-Baddi route on 27 August 2026 under Operation Vajra 2.0.
- The consignment was Alprazolam, Tramadol, Nitrazepam and Clonazepam, carried in 120 master cartons.
- Batch numbers, manufacturing dates and expiry dates had been erased from a substantial quantity of blister strips and boxes.
- Stock marked 'Not to be sold in Punjab Haryana State' was moving into that region without invoices, bilty or e-way bills.
- One person was arrested and an SML Isuzu Sartaj truck seized under the NDPS Act, 1985.
For Prelims
- CBN: the Central Bureau of Narcotics; the seizure was made by its Madhya Pradesh unit on intelligence developed at Neemuch.
- Operation Vajra 2.0: the CBN operation on the Punjab-Himachal Pradesh corridor, run on 27-28 August 2026.
- Seizure: 66,79,980 tablets of Alprazolam, Tramadol, Nitrazepam and Clonazepam in 120 master cartons.
- Pharmaceutical diversion: licitly manufactured medicines moved outside regulated channels, here with batch numbers, manufacturing and expiry dates erased.
- NDPS Act, 1985: the statute under which the tablets, the truck and the accused were seized and arrested.
- Missing documents: invoices, bilty and e-way bills — the transport paperwork whose absence marks an untracked consignment.
- Label restriction: stock printed 'Not to be sold in Punjab Haryana State' was being carried into that region.
- CBN in 2026: 197 cases, 272 arrests, six clandestine laboratories, about 51,000 kg of drugs and 12.72 crore tablets and capsules.
For UPSC: The current example for pharmaceutical diversion as a category distinct from narcotics smuggling. Use it on drug trafficking and organised crime, on regulation of the licit pharmaceutical supply chain, and on the synthetic-drug problem in the north-western states.
What it is NOT: This is not a smuggling case — the tablets are legally manufactured medicines that left the regulated supply chain, which is why the enforcement problem is traceability rather than interdiction at a border.
For Mains
Syllabus: GS3.19 · GS3.17 · Linkage L1
Anchor
The seized stock carried a printed instruction not to sell it in Punjab or Haryana and was being driven into exactly that region — the restriction and its breach travelled in the same carton.
Substantiation (data)
66,79,980 tablets in 120 master cartons on the Chandigarh-Baddi route, one arrest, against a calendar-year record of 197 cases, 272 arrests, six clandestine laboratories and about 51,000 kg of drugs seized.
Exemplification
Erasing batch numbers, manufacturing dates and expiry dates from blister strips removes the only link between a tablet and the factory that made it.
Problematisation
One arrest against 66.80 lakh tablets measures the gap: the carrier is caught at the roadside while the manufacturer and the distributor sit upstream and downstream of the seizure.
Way-forward
The investigation's stated direction — upstream manufacturing and downstream distribution — is the only one that matters, because a diversion network is defined by the licensed unit at its head.
Position
The synthetic-drug problem here is a regulatory failure rather than a border one: this volume came off a legitimate production line and needed only a truck and missing paperwork to reach the market.
Deploys into: Organised crime + internal security agencies (GS3.19, GS3.17) · diversion from the licit pharmaceutical supply chain and traceability as an enforcement instrument.
Ministry of Finance · 2026-08-29 · PRID 2304526 · PIB source ↗